On February 26, the House Energy & Commerce Health Subcommittee held a hearing to address the impact of pharmacy benefit managers (PBMs) on the cost of health care. The Association for Clinical ...

The Conquer Cancer Patient Advocate Award Program helps patient advocates attend ASCO Meetings to learn of important advances in their areas of interest. As of July 2024, more than 1,150 patient ...

To continue, please click on one of the buttons below or access other content through the navigation menu or search.

The Association for Clinical Oncology (ASCO) is one of nearly 50 specialty groups urging the National Institutes of Health (NIH) to rescind a recent policy change limiting how much research ...

ASCO is committed to promoting prevention science and integrating evidence-based prevention strategies into oncology practice. ASCO’s prevention goals are to promote clinical, behavioral, and ...

BOLERO-4: Multicenter, open-label, phase II study of everolimus plus letrozole as first-line therapy in ER + HER2-metastatic breast cancer.

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On February 14, 2025, the Food and Drug Administration approved vimseltinib (Romvimza, ...

Radioparp: A phase I of olaparib with radiation therapy (RT) in patients with inflammatory, locoregionally advanced or metastatic triple-negative breast cancer (TNBC) or patient with operated TNBC ...

The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...

The Resilience Skills Training Program aims to improve physician wellness in oncology through a proactive approach. The program targets current trainees to help create a culture change surrounding ...

The Association for Clinical Oncology (ASCO) works to ensure that all people with cancer have access to high-quality, affordable cancer care, no matter who they are or where they live. ASCO advocates ...

Over the last 50 years, research funded by the National Institutes of Health (NIH) and National Cancer Institute (NCI) has played a role in every major advancement related to cancer prevention, ...